KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Exelixis (EXEL) over the last 15 years, with Jan 2025 value amounting to $217.4 million.

  • Exelixis' Cash & Equivalents rose 45.66% to $376.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $376.3 million, marking a year-over-year increase of 45.66%. This contributed to the annual value of $217.4 million for FY2025, which is 17.35% down from last year.
  • Per Exelixis' latest filing, its Cash & Equivalents stood at $217.4 million for FY2025, which was down 17.35% from $263.0 million recorded in FY2023.
  • In the past 5 years, Exelixis' Cash & Equivalents ranged from a high of $647.2 million in FY2021 and a low of $217.4 million during FY2025.
  • Its 2-year average for Cash & Equivalents is $240.2 million, with a median of $240.2 million in 2023.
  • Per our database at Business Quant, Exelixis' Cash & Equivalents soared by 102.74% in 2021 and then slumped by 47.53% in 2023.
  • Exelixis' Cash & Equivalents (Yearly) stood at $319.2 million in 2021, then skyrocketed by 102.74% to $647.2 million in 2021, then dropped by 22.56% to $501.2 million in 2022, then slumped by 47.53% to $263.0 million in 2023, then declined by 17.35% to $217.4 million in 2025.